scispace - formally typeset
B

Bridgeen Callan

Researcher at Ulster University

Publications -  29
Citations -  1101

Bridgeen Callan is an academic researcher from Ulster University. The author has contributed to research in topics: Sonodynamic therapy & Drug delivery. The author has an hindex of 14, co-authored 28 publications receiving 738 citations.

Papers
More filters
Book ChapterDOI

Sonodynamic Therapy: Concept, Mechanism and Application to Cancer Treatment.

TL;DR: The breath of evidence from in-vitro and in- vivo SDT-based studies is explored, providing the reader with an insight into the therapeutic potential offered by SDT in the treatment of cancer.
Journal ArticleDOI

Iodinated cyanine dyes: a new class of sensitisers for use in NIR activated photodynamic therapy (PDT)

TL;DR: A new class of iodinated cyanine dyes have been prepared for use in NIR excited photodynamic therapy (PDT) and demonstrated improved efficacy in two pancreatic cell lines as well as excellent tumour control in a murine model of the disease.
Journal ArticleDOI

Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.

TL;DR: The use of MBs to facilitate delivery of O2 as well as the sensitisers/antimetabolite, combined with the possibility to activate the sensitiser using externally applied ultrasound, provides a more targeted approach with improved efficacy and reduced side effects when compared with conventional systemic administration of antimetabolite drugs alone.
Journal ArticleDOI

Gemcitabine loaded Microbubbles for Targeted Chemo-Sonodynamic Therapy of Pancreatic Cancer

TL;DR: The results presented in this manuscript suggest that chemo‐sonodynamic therapy using the O2 MB‐Gem and O2MB‐RB conjugates, is potentially an effective targeted and safe treatment modality for pancreatic cancer.
Journal ArticleDOI

Oxygen Generating Nanoparticles for Improved Photodynamic Therapy of Hypoxic Tumours.

TL;DR: The results suggest that the polymer coated CaO2 NP formulation offers significant potential as an in situ method for oxygen generation to enhance the efficacy of treatments that depend on the presence of oxygen to elicit a cytotoxic effect.